Obsidian Therapeutics Inc. (OBX) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4

Key dataNov 4, 2026

Open$13.55

From 52W high−68.60%

Volume543946.00

Market cap$678.88M

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataNov 4, 2026

Open

$13.55

From 52W high

−68.60%

Volume

543946.00

Market cap

$678.88M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

P/E (TTM)

—

RSI (14)

36.8

MomentumView details →

1D Return

−16.93%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

—

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

—

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

—

ROA (TTM)

—

Asset Turnover

—

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

—

MomentumView details →

1D Return

−16.93%

YTD Return

—

1Y Return

—

RSI (14)

36.8

vs 50D SMA

−20.44%

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

—

Quick Ratio

—

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$2.05

EPS Surprise

0.00%

Beats (12Q)

0/12

Next Q EPS Est

—

Avg Surprise (4Q)

0.00%

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

—

Net Income (TTM)

—

Op. CF (TTM)

—

Next earningsNov 17, 2026 →

Latest newsMore news →

No recent news for OBX.

Similar companies

4D Molecular Therapeutics, Inc.FDMT Kura Oncology, Inc.KURA Aura Biosciences, Inc.AURA Candel Therapeutics, Inc.CADL Design Therapeutics, Inc.DSGN ArriVent BioPharma, Inc. Common StockAVBP Find similar companies →

Latest newsMore news →

No recent news for OBX.